EPITIQUE (EPTQ) 500

Epitique (e.p.t.q.)

Dermal Filler

High-density cross-linked hyaluronic acid dermal filler

CE Marked medical device dermal filler (E.P.T.Q line – CE certificate number commonly referenced as CE 2292 for the range).
Manufactured under ISO 13485 and Good Manufacturing Practice (GMP) quality systems (as reported for the e.p.t.q. range).
Korean MFDS (KFDA) approval for hyaluronic acid dermal filler indications (for the e.p.t.q. portfolio).

CE Marked medical device dermal filler (E.P.T.Q line – CE certificate number commonly referenced as CE 2292 for the range).
Manufactured under ISO 13485 and Good Manufacturing Practice (GMP) quality systems (as reported for the e.p.t.q. range).
Korean MFDS (KFDA) approval for hyaluronic acid dermal filler indications (for the e.p.t.q. portfolio).
Low endotoxin and residual BDDE levels in line with international safety standards for cross Linked HA fillers.
All products supplied by Aesthetics Warehouse are stated as CE or CPNP registered where required.

Description

EPITIQUE (EPTQ) 500 is a CE-marked, monophasic, high-density, cross-linked hyaluronic acid dermal filler with lidocaine, designed for advanced facial sculpting and correction of severe volume loss. With 24 mg/ml of non-animal, highly purified HA and 0.3% lidocaine, it delivers significant volume enhancement and contouring of areas such as cheeks, jawline, chin and nasal bridge, while minimising swelling and migration. Its high viscoelasticity and cohesive gel structure support precise, long-lasting results when injected by trained healthcare professionals.

Bnefits

Biocompatible, non-animal hyaluronic acid integrates naturally into the skin for smooth, natural-looking results.
High-density, highly cross-linked gel provides powerful lifting capacity and volume restoration for severe volume loss.
Minimised migration for accurate sculpting and stable, well-defined contours.
Lidocaine 0.3% is included to enhance patient comfort and provide a smoother injection experience.
Monophasic, homogeneous gel with optimised injection pressure for consistent, even extrusion and injector control.
High-purity HA with endotoxin level typically below 0.1 EU/ml to reduce the risk of post-treatment swelling and inflammatory reactions.
Formulated using advanced manufacturing processes (e.g. ZEEP / “9 Process”) to ensure low residual BDDE and high safety.
CE-marked dermal filler suitable for professional aesthetic use in the UK and EU.
Designed to deliver long-lasting results, typically up to 12–18 months depending on treatment area and patient factors.

Indications

Correction of severe facial wrinkles and folds (e.g. deep nasolabial folds, marionette lines) in appropriately selected patients.
Restoration of volume in hollow cheeks and temporal regions.
Jawline and chin augmentation for improved definition and contour.
Non-surgical nasal bridge augmentation (liquid rhinoplasty by trained specialists).
Lip augmentation and enhancement where a high-density filler is clinically appropriate.
General mid-face and lower-face contouring for significant volume loss, when used by trained healthcare professionals.